
Cytomab 100mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Rituximab (100mg)
Overview Cytomab 100mg Injection
Rituximab 100mg injection treats various conditions, including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangiitis. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your specific condition and may adjust over time. Strict adherence to the prescribed regimen is crucial; improper usage can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, potentially taking weeks or months to manifest; discontinue only under medical guidance. Common side effects include headaches, fatigue, swelling, infections, and alopecia. The medication can decrease blood cell counts, increasing infection risk; regular blood tests, including hepatitis B monitoring, are essential. Prior to commencing treatment, inform your doctor of any pre-existing heart or liver conditions, planned surgeries or vaccinations, or concurrent medications, especially those for infections. Significant drug interactions are possible; disclose all medications to your physician. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is mandatory for both partners throughout treatment.
Primary Ingredients of Cytomab 100mg Injection
No information provided. Unable to rephrase.
Uses of Cytomab 100mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin's lymphoma.
Major Benefits of Cytomab 100mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cytomab 100mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Cytomab 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cytomab 100mg Injection works:
The injectable drug Cytomab (100mg) is a monoclonal antibody therapy. Its mechanism involves neutralizing the aberrant function of B lymphocytes, thereby providing benefit in rheumatoid arthritis and specific malignancies.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Cytomab 100mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Cytomab 100mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Cytomab 100mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Cytomab 100mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Cytomab 100mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, but physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data on Cytomab 100mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised. Cytomab 100mg Injection is contraindicated in patients with active liver disease or a history of viral hepatitis due to the risk of infection recurrence.
What if you forget to take Cytomab 100mg Injection :
Should you forget a dose of Cytomab 100mg Injection, seek your physician's advice.
Facts to Know About Cytomab 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Good Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Actions | Anti-CD20 Therapy |
